Once Weekly Exenatide Versus Insulin Detemir in Type 2 Diabetes

• Research type

  Research Study

• Full title

  Efficacy of Once-Weekly Exenatide versus Once or Twice Daily Insulin Detemir in Patients with Type 2 Diabetes Treated with Metformin Alone or in Combination with Sulphonylurea

• IRAS ID

  24938

• Contact name

  Arash Tahbaz

• Contact email

  tahbaz_arash@lilly.com

• Sponsor organisation

  Eli Lilly and Company

• Eudract number

  2009-010830-23

• ISRCTN Number

  N/A

• Research summary

  Eli Lilly would prefer that a lay summary was not published on the NRES website at this stage. We would be happy to forward a summary within 21 days of first patient visit (planned to be by the 11th November 2009), when this information will also be posted on the clinialtrials.gov website.

• REC name

  London - South East Research Ethics Committee

• REC reference

  09/H1102/74

• Date of REC Opinion

  14 Aug 2009

• REC opinion

  Further Information Favourable Opinion